CMPS

Compass Pathways 2025 Financial Review

Compass Pathways 2025 Financial Review

Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental health conditions…

COMPASS Pathways plc (CMPS) Reports Q4 Earnings

COMPASS Pathways plc (CMPS) reported Q4 2025 GAAP earnings of -$1.00 per share.

COMPASS Pathways PLC (CMPS) Q2 2022 earnings call

COMPASS Pathways PLC (NASDAQ: CMPS) Q2 2022 Earnings Conference

COMPASS Pathways PLC (CMPS) Q4 2021 earnings call

COMPASS Pathways PLC (NASDAQ: CMPS) Q4 2021 Earnings Conference

COMPASS Pathways PLC (CMPS) Q2 2021 Earnings Conference Call

COMPASS Pathways PLC (NASDAQ: CMPS) Q2 2021 Earnings Conference

COMPASS Pathways PLC (CMPS) Q1 2021 Earnings Call

COMPASS Pathways PLC (NASDAQ: CMPS) Q1 2021 Earnings Conference

COMPASS Pathways PLC (CMPS) COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

COMPASS Pathways PLC (NASDAQ: CMPS) Q4 2020 Earnings Conference